摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-isopropylcyclohex-2-en-1-one | 43209-90-1

中文名称
——
中文别名
——
英文名称
6-isopropylcyclohex-2-en-1-one
英文别名
6-isopropyl-2-cyclohexen-1-one;6-isopropylcyclohex-2-en-1-ol;6-Isopropyl-cyclohexen-(2)-on-(1);1-Isopropylcyclohex-5-enon;6-isopropyl-cyclohex-2-enone;6-Isopropyl-cyclohex-2-enon;6-propan-2-ylcyclohex-2-en-1-one
6-isopropylcyclohex-2-en-1-one化学式
CAS
43209-90-1
化学式
C9H14O
mdl
——
分子量
138.21
InChiKey
RDSYFWVRUCJTON-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    94.0-94.3 °C(Press: 18 Torr)
  • 密度:
    0.931±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

SDS

SDS:ac2ab31b061b73c96182d7c8f6007530
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Arginase Inhibitors and Their Therapeutic Applications
    申请人:OncoArendi Therapeutics S.A.
    公开号:US20170319536A1
    公开(公告)日:2017-11-09
    Disclosed are small molecule therapeutic compounds that are potent inhibitors of arginase 1 and arginase 2 activity. Also disclosed are pharmaceutical compositions comprising the compounds, and methods for using the compounds for treating or preventing a disease or condition associated with arginase activity.
    揭示了一种小分子治疗化合物,它们是较强的精氨酸酶1和精氨酸酶2活性抑制剂。还揭示了包含这些化合物的药物组合物,以及使用这些化合物治疗或预防与精氨酸酶活性相关的疾病或状况的方法。
  • Synthesis of (Difluoromethyl)cycloalkenes from 2‐Cycloalkenones by Utilizing Phospha‐Brook Rearrangement
    作者:Yoshihiko Yamamoto、Yuki Ishida、Yosuke Takamizu、Takeshi Yasui
    DOI:10.1002/adsc.201900469
    日期:2019.8.21
    Difluoromethyl‐substituted allylic phosphates were synthesized from 2‐cycloalkenones through the addition of a (difluoromethyl)phosphonate and subsequent phospha‐Brook rearrangement. The obtained allylic phosphates were converted to the corresponding difluoromethyl‐substituted cycloalkenes using the Cu‐mediated SN2’ reaction of Grignard or organolithium reagents.
    通过添加(二氟甲基)膦酸酯和随后的Pha-Brook重排,由2-环烯酮合成二氟甲基取代的烯丙基磷酸酯。使用格氏试剂或有机锂试剂的Cu介导的S N 2'反应,将获得的烯丙基磷酸酯转化为相应的二氟甲基取代的环烯烃。
  • o-DPPB-Directed Copper-Mediated and -Catalyzed Allylic Substitution with Grignard Reagents
    作者:Peter Demel、Manfred Keller、Bernhard Breit
    DOI:10.1002/chem.200600225
    日期:2006.8.25
    explored as a directing leaving group in copper-mediated and copper-catalyzed allylic substitution with Grignard reagents. Complete control of chemo-, regio- and stereoselectivity with complete syn-1,3-chirality transfer was observed as a result of the directed nature of the reaction. No excess of organometallic reagent is required and the directing group can be recovered quantitatively. Coordination
    研究了邻二苯基膦基苯甲酰基(o-DPPB)基团作为用格氏试剂在铜介导的和铜催化的烯丙基取代中的直接离去基团。作为反应的定向性质的结果,观察到化学,区域和立体选择性的完全控制以及syn-1,3-手性的完全转移。不需要过量的有机金属试剂,并且可以定量回收导向基团。在固态和溶液中的配位研究表明,两个底物通过铜上导向基团的膦功能键合。溶液中的动态NMR实验与铜的配位体交换过程相一致,这是发展亚化学计量过程的前提。
  • [EN] COMPOUNDS AS MODULATORS OF TLR2 SIGNALING<br/>[FR] COMPOSÉS UTILISÉS EN TANT QUE MODULATEURS DE SIGNALISATION TLR2
    申请人:NEUROPORE THERAPIES INC
    公开号:WO2019191189A1
    公开(公告)日:2019-10-03
    The present disclosure relates to compounds, pharmaceutical compositions comprising such compounds, and use of such compounds in methods of treatment or in medicaments for treatment of inflammatory diseases and certain neurological disorders that are related to inflammatory signaling processes, including but not limited to misfolded proteins.
    本公开涉及化合物、包含这种化合物的药物组合物,以及利用这些化合物进行治疗方法或用于治疗与炎症信号传导过程相关的炎症性疾病和某些神经系统疾病的药物。这些神经系统疾病与炎症信号传导过程有关,包括但不限于蛋白质错折。
  • Copper ‘ate’ complexes of α-ethoxyvinyl-lithium: reagents for coupling and 1,4 addition of a masked acyl anion
    作者:Robert K. Boeckman、Kenneth J. Bruza、J. E. Baldwin、O. W. Lever
    DOI:10.1039/c39750000519
    日期:——
    Stoicheiometric and mixed organocuprate reagents have been prepared from α-ethoxyvinyl-lithium and undergo ready conjugate addition and coupling reactions.
    由α-乙氧基乙烯基锂制备了化学计量的和混合的有机铜酸盐试剂,并进行了共轭加成和偶联反应。
查看更多